Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.8fepf Regulatory News (SANB)

Share Price Information for Sant Uk.8fepf (SANB)

Share Price is delayed by 15 minutes
Get Live Data
142.00    0.00 (0.00%)
Bid:
139.00
Ask:
144.00
Spread: 5.00 (3.597%)
Market Cap: -
SANB Live PriceLast checked at - London Stock Exchange

Intraday Sant Uk.8fepf Share Chart

Final Terms

26 Feb 2026 10:45

RNS Number : 5594U
Santander UK Plc
26 February 2026
 

AMENDED FINAL TERMS

 

Santander UK plc (the "Issuer")

 

 

This notice relates to the following securities (the "Securities") to be issued by the Issuer on 28 April 2026 under its Structured Note and Certificate Programme:

 

Series 1314

ISIN: XS3254389326

 

The Issuer hereby gives notice that the Final Terms dated 19 January 2026 in respect of the Securities (the "Original Final Terms") are amended and restated by a new set of Final Terms dated 25 February 2026 (the "Amended Final Terms"). The Amended Final Terms replace the Original Final Terms.

To view a form of the Amended Final Terms showing the changes made to the Original Final Terms, please click on the link below. The Amended Final Terms will also be available on the Issuer's website at https://www.santander.co.uk/about-santander/investor-relations/santander-uk-structured-note-and-certificate-programme.

http://www.rns-pdf.londonstockexchange.com/rns/5594U_1-2026-2-26.pdf

For further information, please contact:

Structured Notes Desk

Tel: +44 (0) 20 7756 7000 or structurednotesafm@santander.co.uk

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus and the Amended Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus and/or the Amended Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and/or the Amended Final Terms is not addressed. Prior to relying on the information contained in the Base Prospectus and/or the Amended Final Terms, you must ascertain from the Base Prospectus and/or the Amended Final Terms whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

The Amended Final Terms referenced herein does not constitute an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act.

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTDZGZZGVFGVZM
12
Date   Source Headline
7th Mar 20254:12 pmRNSPublication of Suppl.Prospcts
7th Mar 202510:30 amRNSAnnual Financial Report
17th Feb 202512:47 pmRNSNotice of Early Redemption Series 1244
17th Feb 202512:45 pmRNSNotice of Early Redemption Series 1217 and 1218
5th Feb 202510:39 amRNSPublication of Suppl.Prospcts
5th Feb 202510:32 amRNSPublication of Suppl.Prospcts
5th Feb 20257:10 amRNSQuarterly Management Statement – Q4 2024
28th Jan 20254:32 pmRNSDirectorate Change
23rd Jan 20253:00 pmRNSPublication of Final Terms
7th Jan 202511:35 amRNSSeries 1241-Early Redemption
13th Dec 202410:00 amRNSDirectorate Change
9th Dec 20244:33 pmRNSPublication of Final Terms
26th Nov 20244:07 pmRNSPublication of Listing Prospectus
20th Nov 20241:13 pmRNSPublication of Suppl.Prospcts
20th Nov 20241:08 pmRNSPublication of Suppl.Prospcts
20th Nov 20247:15 amRNS3rd Quarter Results
18th Nov 20244:06 pmRNSSeries 1237 and 1238 Early Redemption
15th Nov 20244:26 pmRNSThird Quarter 2024 Results Announcement
28th Oct 20246:31 pmRNSThird Quarter 2024 Results Announcement
21st Oct 202410:00 amRNSDirectorate Change
16th Sep 20243:58 pmRNSIssue 1233 and 1234 Early Redemption Notice
9th Sep 20244:24 pmRNSPublication of Final Terms
9th Aug 20242:30 pmRNSPublication of Suppl.Prospcts
9th Aug 20242:29 pmRNSPublication of Suppl.Prospcts
9th Aug 20247:15 amRNSHalf-year Report
24th Jul 202412:28 pmRNSPublication of Suppl.Prospcts
24th Jul 202412:27 pmRNSPublication of Suppl.Prospcts
24th Jul 20247:15 amRNSQuarterly Management Statement Q2 2024
22nd Jul 20243:34 pmRNSCirc re. Early Redemption Series 1229 and 1230
18th Jun 20241:24 pmRNSPublication of Supplementary Prospectus
13th Jun 20243:00 pmRNSBoard Change
31st May 202411:28 amRNSIssue 1202 and 1203 Notice of Early Redemption
24th May 20243:09 pmRNSIssue 1225 and 1226 Notice of Early Redemption
20th May 202412:27 pmRNSPublication of Final Terms
30th Apr 20247:15 amRNSQuarterly Management Statement - Q1 2024
8th Apr 20247:00 amRNSPublication of a Prospectus
3rd Apr 20241:21 pmRNSIssue 1221 and 1222 Early Redemption Notice
18th Mar 20244:51 pmRNSPublication of Final Terms
6th Mar 20248:48 amRNSPublication of a Prospectus
1st Mar 202412:11 pmRNSPublication of Supplementary Prospectus
1st Mar 20247:00 amRNSAnnual Financial Report - 31 December 2023
23rd Feb 20243:36 pmRNSPublication of Final Terms
31st Jan 202412:54 pmRNSPublication of Suppl.Prospcts
31st Jan 202412:49 pmRNSPublication of Suppl.Prospcts
31st Jan 20247:15 amRNSQuarterly Management Statement – Q4 2023
29th Jan 20207:15 amRNSQ4 19 - Quarterly Management Statement
29th Oct 20157:30 amRNS3rd Quarter Results
30th Jul 20157:45 amRNSQuarterly Management Statement - 30 June 2015
30th Sep 20088:57 amRNSStabilisation Notice
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.